Trial Profile
Body Composition and Adipose Tissue in HIV Lipodystrophy: Effects of Tesamorelin Therapy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2022
Price :
$35
*
At a glance
- Drugs Tesamorelin (Primary)
- Indications HIV-associated lipodystrophy syndrome
- Focus Therapeutic Use
- 24 Oct 2022 Planned End Date changed from 30 Apr 2022 to 30 Apr 2023.
- 24 Oct 2022 Planned primary completion date changed from 30 Apr 2022 to 30 Apr 2023.
- 12 Jul 2021 Planned End Date changed from 30 Apr 2021 to 30 Apr 2022.